David Burns

Special Counsel

David Burns’ practice focuses on antitrust and competition law, representing businesses in merger reviews and government investigations before the Department of Justice and Federal Trade Commission, and in antitrust litigation in federal court. David also regularly provides sophisticated counseling for avoidance of antitrust liability on topics such as pharmaceutical patent litigation settlements, IP licensing, joint ventures and the HSR merger review process.

Download full bio 


  • Amryt Pharma to Sell to Chiesi Farmaceutici in $1.48 Billion Cross-Border Transaction  

  • Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion 

  • Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals 

  • ThoughtSpot Brings Valuation to $4.2 Billion With Series F Round 

  • NeoPhotonics Agrees to Sell to Lumentum for $918 Million 

  • View all


  • George Washington University Law School
    JD, with honors, 2011

  • Middlebury College
    BA , 2007

Admissions & Credentials

District of Columbia



  • American Bar Association

Rankings & Accolades

    Super Lawyers Rising Stars: Antitrust (2018-2022)

    Best Lawyers: Antitrust Law, Ones to Watch

    Legal 500: Merger Control (2021)